Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
North American Pharmacal is a healthcare and nutraceutical company best known for its D'Adamo Personalized Nutrition brand. Founded by Dr. Peter D'Adamo, the company develops and markets dietary supplements, vitamins, and herbal formulas specifically formulated to align with an individual's blood type. Their approach is based on the 'Blood Type Diet' theory, which posits that blood type influences an individual's response to food and susceptibility to certain health conditions. In addition to its supplement line, the company provides diagnostic tools such as home blood typing kits and advanced bioinformatics software like SWAMI and OPUS23 for personalized health analysis. The company is headquartered in Connecticut and serves a global market of health-conscious consumers and practitioners.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on North American Pharmacal.